BioCentury
ARTICLE | Financial News

Zynerba completes IPO

August 10, 2015 7:00 AM UTC

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE), Radnor, Pa. Business: Autoimmune, Neurology, Drug delivery Date completed: 2015-08-04 Type: IPO Raised: $42 million Shares: 3 million Price: $14 Shares afte...